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Introduction
Phyllodes tumor (PT) is an uncommon tumor that
mainly occurs in middle-aged to elderly women. It is
composed of epithelial and stromal elements, and the
latter is usually the focus of diagnosis, treatment and
prognosis.1,2 The epithelial part is mostly benign and
draws less attention. However, malignant change of
the epithelial part does happen. Here, we report a
young woman with invasive ductal carcinoma that
arose from a PT.
Case Report
The patient was a 24-year-old woman who had had a
painless tumor over her left breast for 4 years. Sono-
graphic examination showed a 28 × 8 mm hypoechoic
hypervascular tumor. The clinical diagnosis was fibro-
adenoma. However, the breast tumor grew rapidly to
98 × 35 mm in a few months. Core biopsy revealed a
fibroepithelial lesion with a mild increase in stromal
cellularity. With such an extraordinarily rapid growth,
the tumor was excised. The excised tumor was
10 × 8 × 3.5 cm in size, with lobulation and leaf-like
structure in the cut surface (Figure 1A).
Microscopically, the tumor was well circumscribed.
The stroma was moderately cellular with mild cytolog-
ical atypia. The mitotic count in the most active area
was 3 per 10 high-powered field. There was neither
stromal overgrowth nor necrosis. According to the
World Health Organization 2003 grading system, it
was classified as a borderline PT, based on an increase in
mitotic figures. In a focal area, ductal carcinoma in situ
and invasive ductal carcinoma (Nottingham histologi-
cal score 4) were observed (Figure 1B). The invasive
part was 2.5 cm at its greatest dimension and had lost
the myoepithelium (Figure 1C). The carcinoma cells
were immunoreactive for estrogen receptor (90%) and
progesterone receptor (90%), but non-reactive for
HER-2/Neu (1+).
Due to the presence of invasive carcinoma, mastec-
tomy and sentinel lymph node biopsy were performed.
The mastectomy specimen only harbored atypical duc-
tal hyperplasia. Several isolated tumor cells (0.05 mm
in greatest dimension), were demonstrated in 1 out 
of the 2 sentinel lymph nodes by cytokeratin stain
(Figure 1D). The patient then received hormonal
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Invasive carcinoma in phyllodes tumor
Table 1. Invasive carcinoma arising in phyllodes tumors
Case Age (yr) Size (cm) Type of carcinoma LN Reference (year)
1, 2 NA NA Invasive CA (2 cases) NA Norris & Taylor3 (1967)
3 NA NA Squamous cell CA NA Cornog et al4 (1971)
4 45 5.5 Invasive CA Negative Pietruszka & Barnes5 (1978)
5 NA NA Invasive CA NA Azzopardi6 (1978)
6 47 4 Tubular CA NA Leong & Meredith7 (1980)
7 NA NA Invasive CA NA Bassermann & Eiermann8 (1980)
8 60 1.4 Papillary CA NA Cole-Beuglet et al9 (1983)
9 60 4 Invasive CA Negative Klausner et al10 (1983)
10 NA NA Squamous cell CA NA Hunger et al11 (1984)
11 41 5.6 Papillotubular CA Negative Ishida et al12 (1984)
12 47 13 Invasive ductal CA Negative Yasumura et al13 (1988)
13 NA NA Invasive ductal CA NA de Rosa et al14 (1989)
14 47 17 Invasive lobular CA NA Kodama et al15 (2003)
15 26 3.3 Invasive ductal CA Positive (4/13) Parfitt et al16 (2004)
16 NA 3.5 Invasive CA Negative Tokudome et al17 (2005)
17 69 NA Squamous cell CA NA Ramdass & Dindyal7 (2006)
18 54 8.0 Invasive ductal CA Negative Sugie et al8 (2007)
19 24 10 Invasive ductal CA Positive (1/2) Present case (2010)
LN = lymph node; NA = not available; CA = carcinoma.
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Figure 1. (A) Well-circumscribed mass with leaf-like structures on cut surface. The invasive carcinoma component was located at the 
4 to 5 o’clock position of the tumor (arrowhead). (B) Phyllodes tumor with invasive ductal carcinoma (arrowheads) infiltrating the stroma
(hematoxylin & eosin, 20×). (C) Myoepithelial cells were lost in the invasive carcinoma component (arrowheads) (anti-smooth muscle
actin, 20×). (D) Isolated tumor cells demonstrated by cytokeratin (arrowhead) in the sentinel lymph node (anti-cytokeratin, 200×).
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therapy (goserelin acetate and tamoxifen), adjuvant
chemotherapy (500 mg/m2 5-fluorouracil, 75 mg/m2
epirubicin, and 500 mg/m2 cyclophosphamide, for 
6 times) and reconstructive surgery. The tumor did not
recur during 15 months of follow-up.
Discussion
In young women, fibroadenoma is more commonly
encountered than PT or carcinoma. However, any
feature indicative of a more aggressive tumor should
not be missed. In our case, the tumor displayed an
exceedingly fast growth, which resulted partly from
the PT and partly from the coexisting carcinoma.
Malignant transformation of the epithelium in 
PTs is rare. Eighteen patients have been reported
with invasive carcinomas that have arisen in PTs
(Table 1).3–19 Three of these had squamous cell carci-
noma (16.7%), the occurrence of which was more 
frequent than its occurrence in breast carcinoma in
general (< 0.1%).20 As for the status of lymph nodes,
only 1 patient had pathological evidence of lymph node
metastases.16 The reported metastatic rate (10.5%
with the present case included) seems to be lower
than that of ordinary invasive carcinoma of the breast
(20.6–70.1% for different tumor sizes).21 It is also inter-
esting that invasive carcinomas that arise in fibroade-
nomas are associated with lower metastatic rates.22
Such a phenomenon might result from earlier detec-
tion of invasive carcinoma in a coexisting lesion,22 PT
or fibroadenoma. In addition, lymph node metastasis is
also relatively less frequent in squamous cell carcinoma
than ordinary carcinoma of the breast. The more fre-
quent occurrence of squamous cell carcinoma in the
18 cases mentioned above might also have contributed
to the lower metastatic rates. However, the status of
lymph nodes was not fully described in some of these
cases, and there remains the possibility of underesti-
mation of the metastatic rates.
The reported patient with lymph node metastases16
and our patient were young, at 26 and 24 years of age,
respectively. Whether such combined lesions behave
more aggressively in young women warrants further
study.
In conclusion, we should always be alert when
managing a patient with breast tumors that show an
unusual clinical course, irrespective of age. In such cir-
cumstances, further investigation, or at least close 
follow-up, is needed. The combination of 2 tumors,
PT and invasive carcinoma, highlights the impor-
tance of thorough examination of the resection 
specimen.
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